Visit COVID-19 resources

[Skip to Content]

Review of ranibizumab in patients with diabetic macular oedema

7 March 2013

Statement on the rapid review of the technology appraisal of the use of intravitreal ranibizumab in patients with diabetic macular oedema (DMO)

Review of Ranibizumab for DMO